AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $243,000 | +5.2% | 6,936 | +43.7% | 0.01% | +25.0% |
| Q4 2019 | $231,000 | +8.5% | 4,828 | -26.6% | 0.00% | -33.3% |
| Q3 2019 | $213,000 | -65.2% | 6,582 | -27.5% | 0.01% | -75.0% |
| Q1 2019 | $612,000 | -9.1% | 9,075 | +10.3% | 0.02% | -52.0% |
| Q1 2018 | $673,000 | +28.4% | 8,228 | +4.8% | 0.05% | +19.0% |
| Q3 2017 | $524,000 | -11.9% | 7,851 | -22.9% | 0.04% | -23.6% |
| Q1 2017 | $595,000 | -9.2% | 10,189 | +72.8% | 0.06% | -52.2% |
| Q2 2015 | $655,000 | – | 5,895 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |